Search
-
Ignite Growth with Collective Innovation
Ipsos, one of the world’s leading market research companies, announces today the launch of Collective Innovation, an end-to-end offer designed to help businesses accelerate their innovation development with higher success rates.
-
Building a better future with Innovation
At Ipsos, we are passionate about helping clients identify, qualify, optimise and forecast the business potential of innovations for consumer goods, services and durables, products, packaging and new business models. Our rapid and validated end-to-end solutions, combine optimisation with qualification, to enable clients to be faster in seizing opportunities and be more agile and confident in bringing their products to market.
-
Testing a sustainable replenishment model with a reusable pack
Ipsos gives businesses, governments and public bodies the confidence they need to take the right actions for the benefit of people and the planet, to drive long-term prosperity for all. Discover how.
-
New research from Synthesio and Twitter explores wellness conversations online
Synthesio has released a new report exploring the #Wellness community on Twitter to uncover the top trends that brand marketers and insights pros need to know as they head into 2023.
-
Beyond the Hype: Innovation predictions in the era of Machine Learning
Artificial intelligence (AI) has grown in popularity in recent years. Voice and facial recognition software is developed in all technical gadgets. In this context, we are also beginning to see how AI can also alter market research, resulting in faster, cheaper, and better results.
-
Navigating the fragmented world of emerging channels and shoppable touchpoints
This paper explores some of the emerging channels where convergent commerce is evident, their impacts on shopper journeys and touchpoint use, and what it means for brands.
-
Using machine intelligence to spot unmet customer needs
Machine intelligence does a great job helping us navigate between complex contextual layers – something that is not easily available.
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.